Immunohistology of Lung and Pleural Neoplasms

Diagnostic Immunohistochemistry, Second Edition

Volumn , Issue , 2006, Pages 329-403

  Hammar, Samuel P ^a  

^a Diagnostic Specialties Laboratory Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882796270     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06652-8.50017-X     Document Type: Chapter

References (445)

1. H Han, RJ Landreneaux, TS Santucci, et al. (2002) Prognostic value of immunohistochemical expression of p53, HER-2-neu and bcl-2 in stage I nonsmall cell lung cancer. Hum Pathol 33 105-110.
2. K Minami, Y Saito, H Imamura, et al. (2002) Prognostic significance of p53, Ki67, VEGF and GLUT-1 in resected stage I adenocarcinoma of the lung. Lung Cancer 38 51-57.
3. K Nakanishi, T Kawai, F Kumaki, et al. (2003) Survivin expression in atypical adenomatous hyperplasia of the lung. Am J Clin Pathol 120 712-719.
4. NH Yamaguchi, AJ Lichetenfels, LMM Demarchi, et al. (2004) Cox-2, MMP-9 and Noguchi classification provide additional prognostic information about adenocarcinomas of the lung: a study of 117 patients from Brazil. Am J Clin Pathol 121 78-86.
5. RS Saad, Y Liu, H Han, et al. (2004) Prognostic significance of HER2/neu, p53 and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol 17 1234-1242.
6. G Pelosi, F Pasini, F Fraggetta, et al. (2003) Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42 203-213.
7. G Pelosi, O Pastorini, F Pasini, et al. (2003) Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 88 537-547.
8. SP Hammar (1994) Common neoplasms. DH Dail, SP Hammar (Eds) Pulmonary pathology 2nd edn New York: Springer-Verlag 1487-1579.
9. L Dodds, S Davis and L Polissar (1986) A population-based study of lung cancer incidence by histological type. J Natl Cancer Inst 76 21-29.
10. MJ Thun, CA Lally, JT Flannery, et al. (1997) Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89 1580-1586.
11. R Moll, WW Franke, DL Schiller, et al. (1982) The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 11-24.
12. R Moll, A Lowe, J Laufer, et al. (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Surg Pathol 140 427-447.
13. F Ramaekers, A Huysmans, G Schaart, et al. (1987) Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Research 170 235-249.
14. P Chu, E Wu and LM Weiss (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 13 962-972.
15. V Kaimaktchiev, L Terracciano, L Tornillo, et al. (2004) The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal carcinomas. Mod Pathol 17 1392-1399.
16. NHC Au, AM Gown, M Cheang, et al. (2004) p63 expression in lung carcinomas: A tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 12 240-247.
17. HA Sheikh, K Fuhrer, K Cieply, et al. (2004) p63 expression in assessment of bronchioloalveolar proliferations of the lung. Mod Pathol 17 1134-1140.
18. Y Nakatani, Y Miyagi, T Takemura, et al. (2004) Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful in distinguishing between classic pulmonary blastoma and a blastomatoid variant carcinosarcoma. Am J Surg Pathol 28 921-927.
19. SP Hammar and KO Hallman (1990) Unusual primary lung neoplasms: spindle cell and undifferentiated carcinomas expressing only vimentin. Ultrastruct Pathol 14 407-422.
20. MP Upton, S Hirohashi, Y Tome, et al. (1986) Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 10 560-567.
21. SP Hammar (1998) Metastatic adenocarcinoma of unknown primary origin. Hum Pathol 29 1393-1402.
22. S Guazzi, M Price, M DeFelice, et al. (1990) Thyroid transcription factor-1 (TTF-1) contains a homeodomain and displays a novel DNA-binding specificity. EMBO J 9 3631-3639.
23. D Lazzaro, M Price, M DeFelice, et al. (1991) The transcription factor TTF-1 expressed at the onset of thyroid and lung morphogenesis and in the restricted regions of the foetal brain. Development 113 1093-1094.
24. RJ Bohinski, R DiLauro and JA Whitsett (1994) The lung specific surfactant protein B promoter is a target for thyroid transcription factor-1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 14 5671-5678.
25. RJ Bohinski, JA Huffman, JA Whitsett, et al. (1993) Cis-active elements controlling lung cell-specific expression of human pulmonary surfactant B gene. J Biol Chem 268 11160-11166.
26. PA Bejarano, RP Baughman, PW Biddinger, et al. (1996) Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9 445-452.
27. D Fabbro, C DiLoreto, O Stamerra, et al. (1996) TTF-1 gene expression in human lung tumors. Eur J Cancer 32A 512-573.
28. C DiLoreto, V DiLauro, F Puglisi, et al. (1997) Immunohistochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 50 30-32.
29. A Holzinger, S Dingle, PA Bejarano, et al. (1996) Monoclonal antibody to thyroid transcription factor-1: Production, characterization and usefulness in tumor diagnosis. Hybridoma 15 49-53.
30. AL Folpe, AM Gown, LW Lamps, et al. (1999) Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12 5-8.
31. MB Amin, P Tamboli and SH Merchant (2002) Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 26 358-364.
32. N Nakamura, E Miyagi, S Murata, et al. (2002) Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol 15 1058-1067.
33. SK Lau, MJ Desrochers and DJ Luthringer (2002) Expression of thyroid transcription factor-1, cytokeratin 7 and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Mod Pathol 15 538-542.
34. A Simsir, XJ Wei, H Yee, et al. (2004) Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine needle aspiration biopsy specimens. Am J Clin Pathol 11 350-357.
35. L Johansson (2004) Histopathologic classification of lung cancer: relevance of cytokeratin and TTF-1 immunophenotyping. Ann Diagn Pathol 8 259-267.
36. Y Yatabe, T Mitsudomi and T Takahashi (2002) TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 26 767-773.
37. Y Chang, Y Lee, W Lia, et al. (2004) The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 44 149-157.
38. RS Saad, YL Liu, H Han, et al. (2004) Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Hum Pathol 35 3-7.
39. R Yesner (1983) Small cell tumors of the lung. Am J Surg Pathol 7 775-785.
40. D Carter (1983) Small-cell carcinoma of the lung. Am J Surg Pathol 7 787-795.
41. R Yesner (1985) Classification of lung cancer histology. N Engl J Med 312 652-653.
42. MG Arrigoni, LB Woolner and PE Berantz (1972) Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64 413-421.
43. H Leschke (1956) Über nur regionär bösartige und über krebsig entartete Bronchusadenome bzw. Carcinoide. Virch Arch [Pathol Anat] 328 635-657.
44. WH Warren, VA Memoli and VE Gould (1984) Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms: II. Well-differentiated neuroendocrine carcinomas. Ultrastruct Pathol 7 185-199.
45. EJ Mark and JF Ramirerz (1985) Peripheral small-cell carcinoma of the lung resembling carcinoid tumor: a clinical and pathologic study of 14 cases. Arch Pathol Lab Med 109 263-269.
46. RR Paladugu, JR Benfield, HY Pak, et al. (1985) Bronchopulmonary Kulchitzky cell carcinomas. Cancer 55 1303-1311.
47. WD Travis, TV Colby, B Corrin, et al. (1999) Histological typing of lung and pleural tumors New York: Springer-Verlag
48. CF Thomas, HD Tazelaar and JR Jett (2001) Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 119 1143-1150.
49. J Slodkowska, R Langfort, P Rudzinski, et al. (1998) Typical and atypical pulmonary carcinoids – pathologic and clinical analysis of 77 cases. Pneumonol Alergol Pol 66 297-303.
50. VE Gould and G Chejfec (1978) Ultrastructural and biochemical analysis of pulmonary ‘undifferentiated’ carcinomas. Hum Pathol 9 377-384.
51. ME Hammond and WT Sause (1985) Large cell neuroendocrine tumors of the lung: Clinical significance and histological definition. Cancer 56 1624-1629.
52. MH Neal, R Kosinki, P Cohen, et al. (1986) Atypical endocrine tumors of the lung: A histologic, ultrastructural and clinical study of 19 cases. Hum Pathol 17 1264-1277.
53. M Barbareschi, C Mariscotti, M Barberis, et al. (1989) Large cell neuroendocrine of the lung. Tumor 75 583-588.
54. EM McDowell, TS Wilson and BF Trump (1981) Atypical endocrine tumors of the lung. Arch Pathol Lab Med 105 20-28.
55. WD Travis, I Linnoila, MG Tsokos, et al. (1991) Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 15 529-533.
56. S Hammar, D Bockus, F Remington, et al. (1989) The unusual spectrum of neuroendocrine lung neoplasms. Ultra Pathol 13 515-560.
57. SX Jiang, T Kameya, M Shoji, et al. (1998) Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 22 526-537.
58. N Sturm, S Lantuejoul, MH Laverriere, et al. (2001) Thyroid transcription factor-1 and cytokeratins 1, 5, 10, 14 (34βE12) expression in basaloid and large cell neuroendocrine carcinomas of the lung. Hum Pathol 32 918-925.
59. KJ Jung, KS Lee, J Han, et al. (2001) Large cell neuroendocrine carcinoma of the lung: clinical, CT and pathologic findings in 11 patients. J Thorac Imaging 16 156-162.
60. J Mazieres, G Daste, L Molinier, et al. (2002) Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer 37 287-292.
61. M Paci, A Cavazza, V Annessi, et al. (2004) Large cell neuroendocrine carcinoma of the lung: a 10 year clinicopathologic retrospective study. Ann Thorac Surg 77 1163-1167.
62. C Doddoli, F Barlesi, B Chetaille, et al. (2004) Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 77 1168-1172.
63. WX Peng, T Sano, T Oyama, et al. (2005) Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. Lung Cancer 47 225-233.
64. AGE Pearse (1972) The diffuse neuroendocrine system: an extension of the APUD concept. S Taylor (Eds) Endocrinology London: Heinemann 145-222.
65. VE Gould and RA DeLellis (1983) The neuroendocrine cell system: its tumors, hyperplasias and dysplasias. SG Silverberg (Eds) Principles and practice of surgical pathology New York: John Wiley 1488-1501.
66. SP Hammar and VE Gould (1988) Neuroendocrine neoplasms. HA Azar (Eds) Pathology of human neoplasms: an atlas of diagnostic electron microscopy and immunohistochemistry New York: Raven Press 333-404.
67. B Jahn, W Schibler, C Ouimet, et al. (1985) A 38,000 dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 82 4137-4141.
68. B Wiedenmann and WW Franke (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41 1017-1028.
69. SW Carmichael and H Winkler (1985) The adrenal chromaffin cell. Sci Am 253 40-49.
70. DT O'Connor and RP Frigon (1984) Chromogranin A, the major catecholamine storage vesicle protein. J Biol Chem 259 3237-3247.
71. P Banks and K Helle (1965) The release of protein from the stimulated adrenal medulla. Biochem J 97 40C-41C.
72. H Haimoto, V Takahashi, T Koshikawa, et al. (1985) Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 52 257-263.
73. S Pahlman, T Esscher and K Nilsson (1986) Expression of gamma-subunit of enolase, neuron-specific enolase in human nonneuroendocrine tumors and derived cell lines. Lab Invest 54 554-560.
74. P Leoncini, EB DeMarco, M Bognoli, et al. (1989) Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors. Pathol Res Pract 185 848-855.
75. P Komminoth, J Roth, PM Lackie, et al. (1991) Polysialic acid of the neural cell adhesion molecule distinguishes small cell carcinoma from carcinoids. Am J Pathol 139 297-304.
76. RE Kibbelaar, CEC Moolenaar, RJAM Michalides, et al. (1989) Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma: diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and nonsmall cell lung cancer. J Pathol 159 23-28.
77. P Bunn, I Linnoila, J Minna, et al. (1985) Small-cell lung cancer, endocrine cells of the fetal bronchus and other neuroendocrine cells express Leu-7 antigenic determinant present on natural killer cells. Blood 65 764-768.
78. F Lonardo, HI Pass and DR Lucas (2003) Immunohistochemistry frequently detects c-Kit expression in pulmonary small cell carcinoma and may help select clinical subsets for a novel form of chemotherapy. Appl Immunohist Mol Morphol 11 51-55.
79. G Pelosi, M Barisella, F Pasini, et al. (2004) CD117 immunoreactivity in stage I adenocarcinoma and squamous carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Mod Pathol 17 711-721.
80. C Casali, A Stefani, G Rossi, et al. (2004) The prognostic role of c-Kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 77 252-253.
81. KJ Butnor, JL Burchette, TA Sporn, et al. (2004) The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Arch Pathol Lab Med 128 538-543.
82. Y Matsuki, A Tanimoto, T Hamada, et al. (2003) Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod Pathol 16 72-78.
83. AR Gibbs and WF Whimster (1995) Tumors of the lung and pleura. CDM Fletcher (Eds) Diagnostic histopathology of tumors Edinburgh: Churchill Livingstone 127-150.
84. DH Dail (1994) Uncommon neoplasms. DH Dail, SP Hammar (Eds) Pulmonary pathology 2nd ed New York: Springer-Verlag 1279-1461.
85. MR Wick and PE Swanson (1993) Carcinosarcomas: current perspective and a historical review of nosologic concepts. Semin Diag Pathol 10 118-127.
86. BJ Addis and B Corrin (1985) Pulmonary blastoma, carcinosarcoma and spindle cell carcinoma: an immunohistochemical study of keratin intermediate filaments. J Pathol 147 291-301.
87. RJ Zarbo, JD Crissman, H Venkat, et al. (1986) Spindle cell carcinoma of the upper aerodigestive tract mucosa: an immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle cell tumors. Am J Surg Pathol 10 741-753.
88. PA Humphrey, MW Scroggs, VL Roggli, et al. (1988) Pulmonary carcinomas with a sarcomatoid element: an immunohistochemical and ultrastructural analysis. Hum Pathol 19 155-165.
89. TV Colby, JE Bilbao, H Battifora, et al. (1989) Primary osteosarcoma of the lung: a reappraisal following immunohistologic study. Arch Pathol Lab Med 113 1147-1150.
90. O Nappi, SD Glasner, PE Swanson, et al. (1994) Biphasic and monophasic sarcomatoid carcinomas of the lung: a reappraisal of ‘carcinosarcomas’ and ‘spindle cell carcinomas.’. Am J Clin Pathol 102 331-340.
91. NF Fishback, WD Travis, CA Moran, et al. (1994) Pleomorphic (spindle/giant cell) carcinoma of the lung. Cancer 73 2936-2945.
92. G Pelosi, F Fraggetta, O Nappi, et al. (2003) Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol 27 1203-1215.
93. MN Koss, L Hochholzer and T O'Leary (1983) Pulmonary blastomas. Cancer 73 265-294.
94. SA Yousem, MR Wick, P Randhawa, et al. (1990) Pulmonary blastoma: an immunohistochemical analysis and comparison with fetal lung in its pseudoglandular stage. Am J Clin Pathol 93 167-175.
95. B Etienne-Mastroianni, L Falchero, L Chalabreysse, et al. (2002) Primary sarcomas of the lung: a clinicopathologic study of 12 cases. Lung Cancer 38 283-290.
96. FP Ognibene, RG Steis, AM Macher, et al. (1985) Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med 102 471-475.
97. SM Garay, M Belenko, E Fazzini, et al. (1987) Pulmonary manifestations of Kaposi's sarcoma. Chest 91 39-43.
98. DA White and RA Matthay (1989) Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis 140 1763-1787.
99. TC McLoud and DP Naidich (1992) Thoracic disease in the immunocompromised patient. Radiol Clin North Am 30 525-554.
100. FP Ognibene and JH Shelhamer (1988) Kaposi's sarcoma. Clin Chest Med 9 459-465.
101. ER Heitzman (1990) Pulmonary neoplastic lymphoproliferative disease in AIDS: a review. Radiology 177 347-351.
102. LJ Purdy, TV Colby, SA Yousem, et al. (1986) Pulmonary Kaposi's sarcoma. Premortem histologic diagnosis. Am J Surg Pathol 10 301-311.
103. KB Hymes, T Cheung, JB Greene, et al. (1981) Kaposi's sarcoma in homosexual men: a report of eight cases. Lancet 2 598-600.
104. Kaposi's sarcoma and Pneumocystis pneumonia in homosexual men – New York City and California. MMWR 30 305-308.
105. GJ Gottlieb and AB Ackerman (1982) Kaposi's sarcoma: an extensively disseminated form in young homosexual men. Hum Pathol 13 882-892.
106. C Adem, MC Aubry, HD Tazelaar, et al. (2001) Metastatic angiosarcoma masquerading as diffuse pulmonary hemorrhage: clinicopathologic analysis of 7 new patients. Arch Pathol Lab Med 125 1562-1565.
107. T Tschernig and R Pabst (2000) Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different disease. Pathobiology 68 1-8.
108. I Richmond, GE Pritchard, T Ashcroft, et al. (1993) Bronchus associated lymphoid tissue (BALT) in human lungs: Its distribution in smokers and nonsmokers. Thorax 48 1130-1134.
109. JJ Swigris, GJ Berry, TA Raffin, et al. (2002) Lymphoid interstitial pneumonia. A narrative review. Chest 122 2150-2164.
110. J Bienenstock, N Johnston and DYE Perey (1973) Bronchial lymphoid tissue. I. Morphologic characteristics. Lab Invest 28 686-692.
111. J Bienenstock, N Johnston and DYE Perey (1973) Bronchial lymphoid tissue II. Functional characteristics. Lab Invest 28 693-698.
112. RJ Pisani, TE Witzit, CY Li, et al. (1990) Confirmation of lymphomatous pulmonary involvement by immunophenotypic and gene rearrangement analysis of broncho-alveolar lavage fluid. Mayo Clin Proc 65 651-656.
113. K Kuroso, T Yumo, WN Rom, et al. (2002) Oligoclonal T cell expansions in pulmonary lymphoproliferative disorders: Demonstration of the frequent occurrence of oligoclonal T cells in human immunodeficiency virus-related lymphoid interstitial pneumonia. Am J Respir Crit Care Med 165 254-259.
114. TV Colby (1995) Lymphoproliferative diseases. DH Dail, SP Hammar, TV Colby (Eds) Pulmonary pathology tumors New York: Springer Verlag 343-368.
115. RS Fraser, PD Pare and NL Muller (Eds) (1999) Lymphoproliferative disorders and leukemia. Diagnosis of diseases of the chest 4th edn Philadelphia: WB Saunders 1269-1330.
116. ES Jaffe, NL Harris, H Stein, et al. (2001) Genetics of tumours of hematopoietic and lymphoid tissues Lyon: IARC Press
117. AG Nicholson (1997) Lymphoproliferative lung disease. B Corrin (Eds) Pathology of lung tumors New York: Churchill Livingstone 213-223.
118. SA Yousem (1997) Lung tumors in the immunocompromised host. B Corrin (Eds) Pathology of lung tumors New York: Churchill Livingstone 189-212.
119. MN Koss (1995) Pulmonary lymphoid disorders. Sem Diagn Pathol 12 158-171.
120. RL Kradin and EG Mark (1983) Benign lymphoid disorders of the lung with a theory regarding their development. Human Pathol 14 857-867.
121. TV Colby (1994) Lymphoproliferative diseases. DH Dail, SP Hammar (Eds) Pulmonary pathology 2nd edn New York: Springer-Verlag 1097-1122.
122. MJ Saldana, AS Patchfsky, HL Israel, et al. (1977) Pulmonary angiitis and granulomatosis. The relationship between histologic features, organ involvement and response to treatment. Hum Pathol 8 391-409.
123. HL Israel, AS Patchfsky and MJ Saldana (1977) Wegener's granulomatosis, lymphomatoid granulomatosis, and benign lymphocytic angiitis and granulomatosis of lung. Recognition and treatment. Ann Intern Med 87 691-699.
124. ES Jaffe, PM Banks, B Natwhani, et al. (2002) Recommendations for reporting of lymphoid neoplasms: A report from the association of directors of anatomic and surgical pathology. The ad hoc committee of reporting of lymphoid neoplasms. Hum Pathol 33 1064-1068.
125. ED His and S Yegaptan (2001) Lymphoma immunophenotyping: A new era in paraffin-sectioned immunohistochemistry. Adv Anatom Pathol 8 218-239.
126. C Rosenow, WR Wilson and FR Cockerill (1985) Pulmonary disease in the immunocompromised host. Mayo Clin Proc 60 473-487.
127. Y Lin, GD Rodriguez, JF Turner, et al. (2001) Plasmablastic lymphoma of the lung: Report of a unique case and review of the literature. Arch Pathol Lab Med 125 282-285.
128. RJ L'Hoste, DA Filippa, PH Lieberman, et al. (1984) Primary pulmonary lymphomas: a clinicopathologic analysis of 36 cases. Cancer 54 1397-1406.
129. AI Radin (1990) Primary pulmonary Hodgkin's disease. Cancer 65 550-563.
130. AA Liebow, CB Carrington and PJ Friedman (1972) Lymphomatoid granulomatosis. Hum Pathol 3 457-558.
131. AL Katzenstein, CB Carrington and AA Liebow (1979) Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 43 360-373.
132. Guinee D, Kingma D, Fishback N, et al. Pulmonary lesions with features of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion (LYT/AIL); evidence for Epstein-Barr virus within B lymphocytes. 1994; USCAP Abstract #881.
133. AS Fauci, BF Haynes, J Costa, et al. (1982) Lymphomatoid granulomatosis: prospective, clinical and therapeutic experience over 10 years. N Engl J Med 306 68-74.
134. T Demirer, DH Dail and DM Aboulafia (1994) Four varied cases of intravascular lymphomatosis and a literature review. Cancer 73 1738-1745.
135. TB Tan, PJ Spaander, M Blaisse, et al. (1988) Angiotropic large cell lymphoma presenting as interstitial lung disease. Thorax 43 578-579.
136. LS Snyder, KR Harmon and RD Estensen (1989) Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest 96 1199-1200.
137. SA Yousem and TB Colby (1990) Intravascular lymphomatosis presenting in the lung. Cancer 65 349-353.
138. JT Pellicone and HB Goldstein (1990) Pulmonary malignant angioendotheliomatosis: presentation with fever and syndrome of inappropriate anti-diuretic hormone. Chest 98 1292-1294.
139. K Takamura, Y Nasuhara, T Mishina, et al. (1997) Intravascular lymphomatosis diagnosed by transbronchial lung biopsy. Eur Respir J 10 955-957.
140. JG Walls, YG Hong, JE Cox, et al. (1999) Pulmonary intravascular lymphomatosis: presentation with dyspnea and air trapping. Chest 115 1207-1210.
141. MQ Ansari, DB Dawson, R Nador, et al. (1996) Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 105 221-229.
142. PM Banks and RA Warnke (2001) Primary effusion lymphoma. WHO classification of tumors of hematopoietic and lymphoid tissues Lyon: IARC Press 179-180.
143. PM Banks, NL Harris and RA Warnke (2004) Primary effusion lymphoma. WD Travis, E Brambilla (Eds) WHO classification of tumors of the lung, pleura and mediastinum Lyon: IARC Press
144. E Cesarman, Y Chang, PS Moore, et al. (1995) Kaposi's sarcoma-associated herpes virus-like DNA sequencing in age-related body cavity lymphoma. N Engl J Med 332 1186-1191.
145. K Aozasa, AM Ohsaw and H Kanno (1997) Pyothoraxassociated lymphoma: a distinctive type of lymphoma strongly associated with Epstein-Barr virus. Adv Anat Pathol 4 58-63.
146. P Gaulard and NL Harris (2004) Pyothoraxassociated lymphoma. WD Travis, E Brambilla (Eds) WHO classification of tumors of the lung, pleura and mediastinum Lyon: IARC Press
147. T Ibuka, M Fukayama, Y Hayashi, et al. (1994) Pyothoraxassociated pleural lymphoma. Cancer 73 738-744.
148. SP Hammar (1994) Pulmonary histiocytosis-X (Langerhans cell granulomatosis). DH Dail, SP Hammar (Eds) Pulmonary pathology 2nd edn New York: Springer-Verlag 567-596.
149. D Carter, AS Patchefsky and CF Mountain (1998) Clear cell lesions. D Carter, AS Patchefsky (Eds) Tumors and tumor-like lesions of the lung Philadelphia: WB Saunders 271-274.
150. F Bonetti, M Pea, G Martigoni, et al. (1994) Clear cell (‘sugar tumor’) of the lung is a lesion strictly related to angiomyolipoma – the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 26 230-236.
151. A Panizo-Santos, I Sola, E de Alava, et al. (2003) Angiomyolipoma and PEComa are immunoreactive for MyoD1 in cell cytoplasmic staining pattern. Appl Immunohistochem Mol Morphol 11 156-160.
152. M Gaffey, S Mills, R Zarbo, et al. (1991) Clear cell tumor of the lung: Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol 15 644-653.
153. EJ Sullivan (1998) Lymphangioleiomyomatosis: a review. Chest 114 1689-1703.
154. S Johnson (1999) Lymphangioleiomyomatosis: clinical features, management and basic mechanism. Thorax 54 254-264.
155. AA Liebow and DS Hubbell (1956) Sclerosing hemangioma (histo-cytoma, xanthoma) of the lung. Cancer 9 53-75.
156. K Sogio, H Yokoyama, S Kanedo, et al. (1992) Sclerosing hemangioma of the lung: radiographic and pathologic study. Ann Thorac Surg 53 295-300.
157. A-LA Katzenstein, JT Gmelich and CB Carrington (1982) Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol 4 343-356.
158. M Devouassoux-Shisheboran, T Hayashi, RI Linnoila, et al. (2000) A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 24 906-916.
159. M Devouassoux-Shisheboran, A de la Fouchardiere, F Thivolet-Bejui, et al. (2004) Endobronchial variant of sclerosing hemangioma of the lung: histological and cytological features on endobronchial material. Mod Pathol 17 252-257.
160. A Miyagawa-Hayashino, HD Tazelaar, DJ Langel, et al. (2003) Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med 127 321-325.
161. JB Beckwith and NF Palmer (1978) Histopathology and prognosis of Wilms' tumor: results from the first national Wilms' tumor study. Cancer 55 2850-2853.
162. EJ Small, GJ Gordon and BB Dahms (1985) Malignant rhabdoid tumor of the heart in an infant. Cancer 55 2850-2853.
163. AJ Balaton, P Vaury and M Videgrain (1987) Paravertebral malignant rhabdoid tumor in an adult: a case report of immunocytochemical study. Pathol Res Pract 182 713-718.
164. M Harris, BP Eyden and VM Joglekar (1987) Rhabdoid tumour of the bladder: a histological, ultrastructural and immunohistochemical study. Histopathology 11 1083-1089.
165. PJ Biggs, PD Garren, JM Posers, et al. (1987) Malignant rhabdoid tumor of the central nervous system. Hum Pathol 18 332-337.
166. PA Dervan, SF Cahalane, P Kneafsey, et al. (1987) Malignant rhabdoid tumor of soft tissue: an ultrastructural and immunohistological study of a pelvic tumour. Histopathol 11 183-190.
167. DM Parham, S Peiper, G Robicheaux, et al. (1988) Malignant rhabdoid tumor of the liver: evidence for epithelial differentiation. Arch Pathol Lab Med 112 61-64.
168. SM Jakate, HB Mardsen and L Ingram (1988) Primary rhabdoid tumour of the brain. Virch Arch [A] 412 393-397.
169. H Uchida, S Yokoyama, I Nakayama, et al. (1988) An autopsy case of malignant rhabdoid tumor arising from soft parts in the left inguinal region. Acta Pathol Jpn 38 1087-1096.
170. M Patron, J Palacious, JL Rodriguez-Peralto, et al. (1988) Malignant rhabdoid tumor of the tongue: a case report with immunohistochemical and ultrastructural findings. Oral Surg Oral Med Oral Path 65 67-70.
171. RL Carter, KP McCarthy, SZ al-Sam, et al. (1989) Malignant rhabdoid tumour of the bladder with immunohistochemical and ultrastructural evidence suggesting histiocytic origin. Histopathology 14 179-190.
172. T Jsujimura, A Wasa, K Kawano, et al. (1989) A case of malignant rhabdoid tumor arising from soft parts of the prepubic region. Acta Pathol Jpn 37 677-682.
173. KR Cho, NB Rosenshein and JI Epstein (1989) Malignant rhabdoid tumor of the kidney and soft tissues: evidence for a diverse morphological and immunocytochemical phenotype. Arch Pathol Lab Med 113 115-120.
174. M Tsokos, G Kouraklis, RS Chandra, et al. (1989) Malignant rhabdoid tumor of the uterus. Int J Gynecol Pathol 8 381-387.
175. WM Molenaar, B DeJong, A Dam-Meiring, et al. (1989) Epithelioid sarcoma or malignant rhabdoid tumor of soft tissue. Epithelioid immunophenotype and rhabdoid karyotype. Hum Pathol 20 347-351.
176. A Cavazza, TV Colby, M Tsokos, et al. (1996) Lung tumors with a rhabdoid phenotype. Am J Clin Pathol 105 182-188.
177. J Miyagi, K Tsuhako, T Kinjo, et al. (2000) Rhabdoid tumor of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma. Histopathology 37 37-44.
178. H Bahadori and AA Liebow (1973) Plasma cell granuloma of the lung. Cancer 31 191-208.
179. JD Lane, S Krohn, W Kolozzi, et al. (1955) Plasma cell granuloma of the lung. Dis Chest 27 216-221.
180. RS Berardi, SS Lee, HP Chen, et al. (1983) Inflammatory pseudotumors of the lung. Surg Gynecol Obstet 156 89-96.
181. TT Tang, AD Segura, HW Oechler, et al. (1990) Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. Cancer 65 1626-1634.
182. NS Tan-Liu, MD Matsubara, HC Grillo, et al. (1989) Invasive fibrous tumor of the tracheobronchial tree: clinical and pathological study of seven cases. Hum Pathol 20 180-184.
183. SC Ledet, RW Brown and PT Cagle (1995) p53 immunostaining of the differentiation of inflammatory pseudotumor from sarcoma involving the lung. Mod Pathol 8 282-286.
184. CS Snyder, M Dell-Aquila, P Haghighi, et al. (1995) Clonal changes in inflammatory pseudotumor of the lung. Cancer 76 1545-1549.
185. SA Yousem, H Shaw and K Cieply (2001) Involvement of 2p23 pulmonary inflammatory pseudotumors. Hum Pathol 32 428-433.
186. A Freeman, N Geddes, P Munson, et al. (2004) Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumors of the bladder: a preliminary clinicopathologic study of nine cases and review of the literature. Mod Pathol 17 765-771.
187. ME Lae, PC Roche, L Jin, et al. (2002) Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical and molecular study of 32 tumors. Am J Surg Pathol 26 823-835.
188. S Syed, AK Hague, HK Hawkins, et al. (2002) Desmoplastic small round cell tumor of the lung. Arch Pathol Lab Med 126 1226-1228.
189. G Ostoros, Z Orosz, G Kovacs, et al. (2002) Desmoplastic small round cell tumor of the pleura: a case report with unusual follow-up. Lung Cancer 36 333-336.
190. N Tsuji, R Tateishi, S Ishigoro, et al. (1995) Adenomyoepithelioma of the lung. Am J Surg Pathol 19 956-962.
191. R Veeramechaneni, J Gulic, AO Halldorsson, et al. (2001) Benign myoepithelioma of the lung: a case report and review of the literature. Arch Pathol Lab Med 125 1494-1496.
192. G Pelosi, F Fraggetta, F Maffini, et al. (2001) Pulmonary epithelial-myoepithelial tumor of unproven malignant potential: report of a case and review of the literature. Mod Pathol 14 521-526.
193. K Ro, A Srivastava and AS Tischer (2004) Bronchial epithelial-myoepithelial carcinoma. Arch Pathol Lab Med 128 92-94.
194. M Dearers, D Guinee, MN Koss, et al. (1995) Granular cell tumors of the lung: clinicopathologic study of 20 cases. Am J Surg Pathol 19 627-635.
195. VC de Araujo, SOM de Sousa, YR Carvalho, et al. (2000) Application of immunohistochemistry to the diagnosis of salivary gland tumors. Appl Immunohist Mol Morphol 8 195-202.
196. CA Moran, S Suster, NF Fishback, et al. (1995) Primary intrapulmonary thymoma: a clinicopathologic and immunohistochemical study of eight cases. Am J Surg Pathol 19 304-312.
197. DN Ionescu, E Sasatomi, D Aldeeb, et al. (2004) Pulmonary meningothelial-like nodules: a genotypic comparison with meningiomas. Am J Surg Pathol 28 207-214.
198. L Hochholzer, CA Moran and MN Koss (1997) Pulmonary lipomatosis: a variant of placental transmogrification. Mod Pathol 10 846-849.
199. ME Fidler, M Koomen, B Sebek, et al. (1995) Placental transmogrification of the lung, a histologic variant of giant bullous emphysema. Am J Surg Pathol 19 563-570.
200. E Brambilla (1997) Basaloid carcinoma of the lung. B Corrin (Eds) Pathology of lung tumors New York: Churchill Livingstone 71-82.
201. N Sturm, S Lantuejoul, M Laverriere, et al. (2001) Thyroid transcription factor-1 and cytokeratins 1, 5, 10 and 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 32 918-925.
202. PA Bejarano and F Mousavi (2003) Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. Arch Pathol Lab Med 127 193-195.
203. G Rossi, B Murer, A Cavazza, et al. (2004) Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX2 homeobox gene and MUC2 expression. Am J Surg Pathol 28 442-452.
204. RM Mazziotta, AC Borczuk, CA Powell, et al. (2005) CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol 13 55-60.
205. GA Herrera, EA Turbat-Herrera and RL Lott (1988) S100 protein expression by primary and metastatic adenocarcinoma. Am J Clin Pathol 89 168-176.
206. SP Hammar, D Bockus, F Remington, et al. (1980) Langerhans cells and serum precipitating antibodies against fungal antigens in bronchioloalveolar cell carcinomas: Possible association with eosinophilic granuloma. Unltrastruct Pathol 1 19-37.
207. A Colasante, G Castrilli, FB Aiello, et al. (1995) Role of cytokines in the distribution of dendritic cells/Langerhans cell lineage in human primary carcinomas of the lung. Hum Pathol 26 866-872.
208. SP Hammar, D Bockus, F Remington, et al. (1986) The widespread distribution of Langerhans cells in pathologic tissues: An ultrastructural and immunohistochemical study. Hum Pathol 17 894-905.
209. C Torikata and K Ishiwata (1977) Intranuclear tubular structures observed in the cells of alveolar cell carcinomas of the lung. Cancer 40 1194-1201.
210. G Singh, SL Katyal and C Torikata (1981) Carcinoma of type II pneumocytes: Immunodiagnosis of a subtype of bronchioloalveolar carcinoma. Am J Pathol 102 195-208.
211. G Singh, SL Katyal and C Torikata (1982) Carcinoma of type II pneumocytes: PAS staining as a screening test for nuclear inclusions of surfactant-specific apoprotein. Cancer 50 946-948.
212. FN Ghadially, S Harawi and W Khan (1985) Diagnostic ultrastructural markers in alveolar cell carcinoma. J Submicrosc Cytol 17 269-278.
213. HJ Abrams, R Spiro and N Goldstein (1950) Metastases in carcinoma, analysis of 1000 autopsied cases. Cancer 3 74-85.
214. DH Dail (1995) Metastases to and from the lung. DH Dail, SP Hammar, TV Colby (Eds) Pulmonary tumors New York: Springer-Verlag 369-403.
215. NP Wang, S Zee, RJ Zarbo, et al. (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohist 3 99-107.
216. CW Ollayos, P Riordan and JM Rushin (1994) Estrogen receptor detection in paraffin section of adenocarcinoma of colon, pancreas and lung. Arch Pathol Lab Med 118 630-632.
217. CC Canver, VA Memoli, PL Vanderveer, et al. (1994) Sex hormones in nonsmall cell lung cancer in human beings. J Thorac Cardiovasc Surg 108 153-157.
218. CE Bacchi, RL Garcia and AM Gown (1997) Immunolocalization of estrogen and progesterone receptors in neuroendocrine tumors of lung, skin, gastrointestinal and female genital tracts. Appl Immunohist 5 17-22.
219. LD DiNunno, LG Larsson, JJ Rinehart, et al. (2000) Estrogen and progesterone receptors in nonsmall cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 124 1467-1470.
220. DJ Dabbs, RJ Landreneau, Y Liu, et al. (2002) Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 73 403-406.
221. G Selvaggi, GV Scagliotti, V Torri, et al. (2002) HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma: impact on long-term survival. Cancer 94 2669-2674.
222. AE Butler, TV Colby, L Weiss, et al. (1989) Lymphoepithelioma-like carcinoma of lung. Am J Surg Pathol 13 632-639.
223. F Chen, J Yan, W Lai, et al. (1998) Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated ‘lympho-epithelioma-like’ carcinomas as a distinct entity with better prognosis. Cancer 82 2334-2342.
224. SS Ginsberg, AC Buzaid, H Stern, et al. (1992) Giant cell carcinoma of the lung. Cancer 70 606-610.
225. C Gustmann, M Altmannsberger, M Osborn, et al. (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphoma and other non-Hodgkin's lymphoma. Am J Pathol 38 1413-1422.
226. G Delsol, T AlSaati, KC Gatter, et al. (1988) Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130 59-70.
227. BM Osborne, B Mockay, JJ Butler, et al. (1983) Large cell lymphoma with microvillus-like projections: an ultrastructural study. Am J Clin Pathol 79 433-450.
228. PG Chu, DA Arber and LM Weiss (2003) Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. Am J Clin Pathol 120 64-70.
229. PW Bishop, LP Menasce, AJ Yates, et al. (1993) An immunophenotypic survey of malignant melanomas. Histopathology 23 159-166.
230. T Yoshimoto, K Higashino, T Hada, et al. (1987) A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin. Cancer 60 2744-2750.
231. CA Kuida, GD Braunstein, P Shintaku, et al. (1988) Human chorionic gonadotropin expression in lung, breast and renal carcinomas. Arch Pathol Lab Med 112 282-285.
232. S Dirnhofer, M Freund, H Rogatsch, et al. (2000) Selective expression of trophoblastic hormones by lung carcinoma: neuroendocrine tumors produce human chorionic gonadotropin alpha-subunit (hCGα). Hum Pathol 31 966-972.
233. M Nasu, T Soma, H Fukushima, et al. (1997) Hepatoid carcinoma of the lung with production of alpha fetoprotein and abnormal prothrombin: an autopsy case report. Mod Pathol 10 1054-1058.
234. WA Cooper, VH Thourani, AA Gal, et al. (2001) The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 119 14-18.
235. MH Lyda and LM Weiss (2000) Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol 31 980-987.
236. N Sturm, G Rossi, S Lantuejoul, et al. (2002) Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 33 175-182.
237. O Lin, S Olgac, I Green, et al. (2003) Immunohistochemical staining of cytologic smears with MIB-1 helps distinguish low-grade from high-grade neuroendocrine neoplasms. Am J Clin Pathol 120 209-216.
238. G Pelosi, J Rodriguez, G Viale, et al. (2005) Typical and atypical pulmonary carcinoid tumor overdiagnosed as small cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 29 179-187.
239. DW Visscher, RJ Zarbo, JQ Trojanowski, et al. (1990) Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistochemical study. Mod Pathol 3 508-512.
240. RI Linnoila, JL Mulshine, SM Steinberg, et al. (1988) Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 90 641-652.
241. WJ Mooi, A Dewar, D Springall, et al. (1988) Nonsmall cell lung carcinomas with neuroendocrine features: a light microscopic, immunohistochemical and ultrastructural study of 11 cases. Histopathology 13 329-337.
242. MR Wick, LC Berg and MI Hertz (1992) Large cell carcinoma of the lung with neuroendocrine differentiation: a comparison with large cell ‘undifferentiated’ pulmonary tumors. Am J Clin Pathol 97 796-805.
243. TS Loy, GVD Darkow and JT Quesenberry (1995) Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas: an immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 19 173-182.
244. JT Schleusener, HD Tazelaar, S Jung, et al. (1996) Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer 77 1284-1291.
245. SP Hammar (1995) Pleural diseases. DH Dail, SP Hammar, TV Colby (Eds) Pulmonary pathology tumors New York: Springer-Verlag 405-530.
246. J Davies (1963) Human developmental anatomy New York: Roland Press 51-52.
247. IJ Selikoff and H Seidman (1991) Asbestos-associated deaths among insulation workers in the United States and Canada, 1967–1987. Annl NY Acad Sci 643 1-14.
248. H Battifora and WTE McCaughey (1995) Tumors of the serosal membranes Washington DC: Armed Forces Institute of Pathology 17-88.
249. KJ Butnor, TA Sporn, SP Hammar, et al. (2001) Well-differentiated papillary mesothelioma. Am J Surg Pathol 25 1304-1309.
250. F Galateau-Salle, J Vignaud, L Burke, et al. (2004) Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 28 534-540.
251. DW Henderson, KB Shilkin and D Whitaker (1998) Reactive mesothelial hyperplasia vs. mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol 110 397-404.
252. US-Canadian Mesothelioma Reference Panel A Churg, TV Colby, P Cagle, et al. (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24 1183-1200.
253. JW Bolen, SP Hammar and MA McNutt (1986) Reactive and neoplastic serosal tissue: a light-microscopic, ultrastructural and immunocytochemical study. Am J Surg Pathol 10 34-47.
254. DW Henderson, CE Comin, SP Hammar, et al. (1997) Malignant mesothelioma of the pleura: current surgical pathology. B Corrin (Eds) Pathology of lung tumors New York: Churchill Livingstone 241-280.
255. NG Ordonez (1999) The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 30 313-323.
256. GA Blobel, R Moll, WW Franke, et al. (1985) The intermediate filament cytoskeleton of malignant mesothelioma and its diagnostic significance. Am J Pathol 121 235-247.
257. GA Blobel, R Moll, WW Franke, et al. (1984) Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch A Cell Pathol 45 407-429.
258. R Moll, D Dhovailly and T-T Sun (1989) Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AE14. Virchows Archiv B Cell Pathol 58 129-145.
259. J Clover, J Oates and C Edwards (1997) Anti-cytokeratin 5/6: a positive marker for epithelial mesothelioma. Histopathology 31 140-143.
260. HJ Kahn, PS Thorner, H Yeager, et al. (1982) Immunohistochemical localization of pre-keratin filaments in benign and malignant cells in effusions: comparison with intermediate filament distribution by electron microscopy. Am J Pathol 109 206-214.
261. HJ Kahn, PS Thorner, H Yeger, et al. (1986) Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids and mesotheliomas using polyclonal and monoclonal keratin antibodies. Am J Clin Pathol 86 566-574.
262. AG Montag, GS Pinkus and JM Corson (1988) Keratin protein reactivity immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesotheliomas: an immunoperoxidase study of 30 cases. Hum Pathol 19 336-342.
263. H Battifora (1989) The pleura. SS Sternberg (Eds) Diagnostic surgical pathology Vol. I New York: Raven Press 829-855.
264. VL Roggli, J Kolbeck, F Sanfilippo, et al. (1987) Pathology of human mesothelioma: etiologic and diagnostic considerations. Pathol Ann 22(pt 2), 91-131.
265. M Al-Izzi, NP Thurlow and B Corrin (1989) Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura and reactive submesothelial hyperplasia: an immunohistochemical comparison. J Pathol 157 41-44.
266. GA Blobel, R Moll, WW Franke, et al. (1985) The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 121 235-247.
267. FG Mayall, H Goddard and AR Gibbs (1992) Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon. Histopathology 21 453-457.
268. SA Yousem and L Hochholzer (1987) Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Invest 111 62-66.
269. PR Wirth, J Legler and GL Wright (1991) Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma. Cancer 67 655-662.
270. D Carter and CN Otis (1988) Three types of spindle cell tumors of pleura: Fibroma, sarcoma and sarcomatoid mesothelioma. Am J Surg Pathol 12 747-753.
271. N Azumi, H Battifora, G Carlson, et al. (1989) Sarcomatous (spindle-cell) mesothelioma of pleura: Immunohistochemical study. Lab Invest 60 4A.
272. DR Lucas, HI Pass, SK Madan, et al. (2003) Sarcomatoid mesothelioma and its histologic mimics. Histopathology 42 270-279.
273. RL Attanoos, SD Dojcinov, R Webb, et al. (2000) Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 37 224-231.
274. MA McNutt, JW Bolen, AM Gown, et al. (1985) Coexpression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol 9 31-43.
275. MP Upton, S Hirohashi, Y Tome, et al. (1986) Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 10 560-567.
276. N Azumi and H Battifora (1987) The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms. A comprehensive study on formalin and alcohol-fixed tumors. Am J Clin Pathol 88 286-296.
277. WA Raymond and AS-Y Leong (1989) Vimentin – a new prognostic marker in breast carcinoma. J Pathol 158 107-114.
278. A Churg (1985) Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 9 360-365.
279. B Jasani, RE Edwards, ND Thomas, et al. (1985) The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virch Arch A Pathol Anat 406 441-448.
280. H Mullink, SC Henzen-Logmans, JJM Alons-van Kordelaan, et al. (1986) Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma. Virch Arch B Pathol Anat 42 55-65.
281. C Andersen, I Blumcke and MR Celio (1993) Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271 181-208.
282. B Schwaller, P Buchwald, I Blucke, et al. (1993) Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 14 639-648.
283. V Gotzos, B Schwaller, N Hertzel, et al. (1992) Expression of the calcium binding protein calretinin in Wi Dr cells and its correlation to their cell cycle. Exp Cell Res 202 292-302.
284. C Doglioni, AP Dei Tos, L Laurino, et al. (1996) Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20 1037-1046.
285. MCP Barberis, M Faleri, S Veronese, et al. (1997) Calretinin: a selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol 41 1757-1761.
286. MPG Leers, MMJ Aarts and PHMH Theunissen (1998) E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathol 32 209-216.
287. NG Ordonez (1998) Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol 10 929-933.
288. MP Chenard-Neu, A Kabou, A Mechine, et al. (1998) Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma: evaluation of 5 new and 6 traditional antibodies. Ann Pathol 18 460-465.
289. PM Cury, DN Butcher, C Fisher, et al. (2000) Value of mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin and CD44H in distinguishing epithelioid mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13 107-112.
290. J Oates and C Edwards (2000) HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 36 341-347.
291. DC Chhieng, H Yee, D Schaefer, et al. (2000) Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 25 194-200.
292. CJ O'Hara, JM Corson, GS Pinkus, et al. (1990) ME1: a monoclonal antibody that distinguishes epithelial-type mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. Am J Pathol 136 421-428.
293. K Sheibani, JM Esteban, A Bailey, et al. (1992) Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23 107-116.
294. SP Hammar, JW Bolen, D Bockus, et al. (1985) Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct Pathol 9 283-318.
295. R Walz and HK Koch (1990) Malignant pleural mesotheliomas: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985. Pathol Res Pract 186 124-134.
296. MR Wick, T Loy, SE Mills, et al. (1990) Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural and immunohistologic study of 103 cases. Hum Pathol 21 759-766.
297. DW Henderson, KB Shilkin, D Whitaker, et al. (1992) The pathology of mesothelioma, including immunohistology and ultrastructure. DW Henderson, KB Shilkin, SL Langlois, et al., (Eds) Malignant mesothelioma New York: Hemisphere 69-139.
298. L Fink, CL Collins, R Schaefer, et al. (1992) Thrombomodulin expression can be used to differentiate between mesotheliomas and adenocarcinomas. Lab Invest 66 113A.
299. CL Collins, NG Ordonez, R Schaefer, et al. (1992) Thrombomodulin expression and pulmonary adenocarcinoma. Am J Pathol 141 827-833.
300. RW Brown, GM Clark, AK Tandon, et al. (1993) Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 24 347-354.
301. V Ascoli, CC Scalzo, S Taccogna, et al. (1995) The diagnostic value of thrombomodulin immunolocalization in serous effusions. Arch Pathol Lab Med 119 1136-1140.
302. B Geiger and O Ayalon (1992) Cadherins. Annu Rev Cell Biol 8 307-332.
303. M Takeichi (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 1451-1455.
304. K Hatta, S Takagi, H Fujisawa, et al. (1987) Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol 120 215-227.
305. A Peralta-Soler, KA Knudsen, MC Jaurand, et al. (1995) The differential expression of N-cadherin, E-cadherin distinguished pleural mesotheliomas from lung adenocarcinomas. Hum Pathol 26 1363-1369.
306. AC Han, A Peralta-Soler, KA Knudsen, et al. (1997) Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol 28 641-645.
307. NG Ordonez (2003) Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol 34 749-755.
308. KM Amin, LA Litzky, WR Smythe, et al. (1995) Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 146 344-356.
309. S Kumar-Singh, K Segers, O Rodeck, et al. (1997) WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 growth factor expression, cell-type transition and prognosis. J Pathol 181 67-74.
310. C Walker, F Rutlen, X Yuan, et al. (1994) Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 54 1301-1306.
311. NG Ordonez (2003) Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 27 1418-1428.
312. AY Chu, LA Litzky, TL Pasha, et al. (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18 105-110.
313. JE Shivley and JD Beatty (1985) CEA-related antigens: molecular biology and clinical significance. CRC Crit Rev Oncol Hematol 2 355-399.
314. J Thompson, F Grunert and W Zimmermann (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Labor Anal 5 344-366.
315. S Hammarstrom, WN Khan, S Teglund, et al. (1993) The carcinoembryonic antigen family. MHV Van Regenmortel (Eds) Structure of antigens Boca Raton: CRC Press 341-376.
316. S Hammarstrom, A Olsen, S Teglund, et al. (1997) The nature and expression of the human CEA family. C Stanners (Eds) Cell adhesion and clinical perspectives Amsterdam: Harwood Academic Publishers 1-30.
317. S Hammarstrom (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Cancer Biol 9 67-81.
318. N-S Wang, S-N Huang and P Gold (1979) Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer 44 437-443.
319. D Whitaker and KB Shilkin (1981) Carcinoembryonic antigen in the tissue diagnosis of malignant mesothelioma. Lancet 1 1369-1370.
320. D Whitaker, GF Sterret and KB Shilkin (1982) Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma. Pathology 14 255-258.
321. K Sheibani and H Battifora (1985) Leu-M1 positivity is not specific for Hodgkin's disease. Am J Clin Pathol 84 682.
322. K Sheibani, H Battifora, JS Burke, et al. (1986) Leu-M1 in human neoplasms: An immunohistologic study of 400 cases. Am J Surg Pathol 10 227-236.
323. K Sheibani, H Battifora and J Burke (1986) Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas: an immunohistologic analysis demonstrating the value of Leu-M1 antigen. Am J Pathol 123 212-219.
324. K Sheibani, N Azumi and H Battifora (1988) Further evidence demonstrating the value of LeuM1 antigen in differential diagnosis of malignant mesothelioma and adenocarcinoma: an immunohistologic evaluation of 395 cases. Lab Invest 58 84A.
325. CN Otis, O Carter, S Cole, et al. (1987) Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. Am J Surg Pathol 11 445-456.
326. CA Szpak, WW Johnston, V Roggli, et al. (1986) The diagnostic distinction between malignant mesothelioma and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3). Am J Pathol 122 252-260.
327. NG Ordonez (1989) The immunohistochemical diagnosis of mesothelioma: Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 13 276-291.
328. DJ Bollinger, MR Wick, LP Dehner, et al. (1989) Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma: A histochemical and immunohistochemical comparison. Am J Surg Pathol 13 659-670.
329. V Latza, G Niedobitek, R Schwarting, et al. (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43 213-219.
330. K Sheibani, SS Shin, J Kezirian, et al. (1991) Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 15 779-784.
331. MJ Gaffey, SE Mills, PE Swanson, et al. (1992) Immunoreactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumors and malignant mesotheliomas. Am J Surg Pathol 16 593-599.
332. RL Souhami, PCL Beverly and LG Bobrow (1987) Antigens of small cell lung cancer. First International Workshop. Lancet 2 325-326.
333. L DeLeij, J Broers, F Ramaekers, et al. (1987) Monoclonal antibodies in clinical and experimental pathology of lung cancer. DJ Roiter, GJ Fleuren, SO Warner (Eds) Applications of monoclonal antibodies in tumor pathology Dordrecht: Martinus Nijhoff 191-210.
334. M Delahaye, HC Hoogsteden and TH van der Kwast (1991) Immunocytochemistry of malignant mesothelioma: OV 632 as a marker of malignant mesothelioma. J Pathol 165 137-143.
335. T Riutenbeek, ASH Gouw and S Poppema (1994) Immunocytology of body cavity fluids: MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 118 265-269.
336. NG Ordonez (1998) Value of MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Hum Pathol 29 166-169.
337. D Jordon, J Jagirdar and M Kaneko (1989) Blood group antigens Lewis x and Lewis y in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol 135 931-937.
338. JR Riera, C Astengo-Osuna, JA Longmate, et al. (1997) The immunohistochemical diagnostic panel for epithelial mesothelioma. A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 21 1409-1419.
339. AR Kinsella, B Green, GC Lepts, et al. (1993) The role of cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer 67 904-909.
340. CL Williams, VY Hayes, AM Hummel, et al. (1993) Regulation of E-cadherin mediated adhesion by muscarinic acetylcholine receptor in small cell lung carcinoma. J Cell Biol 121 643-654.
341. MPG Leers, MMJ Aarts and PTMH Theunissen (1998) E-Cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 32 209-216.
342. T Kawai, M Suzuki, C Torikata, et al. (1991) Expression of blood group-related antigens and Helix pomatia agglutinin in malignant pleural mesothelioma and pulmonary adenocarcinoma. Hum Pathol 22 118-124.
343. FG Mayall, H Goddard and AR Gibbs (1992) p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 168 377-381.
344. M Ramael, G Lemmens, C Eerdekens, et al. (1992) Immunoreactivity for p53 protein in malignant mesothelioma and nonneoplastic mesothelium. J Pathol 168 371-375.
345. FG Mayall, H Goddard and AR Gibbs (1993) The frequency of p53 immunostaining in asbestos-associated mesotheliomas. Histopathology 22 383-386.
346. J Hurlimann (1994) Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol 25 753-757.
347. N Azumi, CB Underhill, E Kagan, et al. (1992) A novel biotinyl-ated probe specific for hyaluronate. Am J Surg Pathol 16 116-121.
348. A Thylen, J Wallin and G Martensson (1999) Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma. Cancer 86 2000-2005.
349. G Martensson, A Thylen, U Lindquist, et al. (1994) The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73 1406-1410.
350. A Thylen, AM Levin-Jacobsen, A Hjerpe, et al. (1997) Immunohistochemical differences between hyaluronan and non-hyaluronan-producing malignant mesothelioma. Eur Respir J 10 404-408.
351. SE Kabawat, RC Bast, AK Bhan, et al. (1983) Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Pathol 79 98-104.
352. SE Kabawat, RC Blast, AK Bhan, et al. (1983) Tissue distribution of celomic epithelium related antigen recognized by monoclonal antibody OC-125. Int J Gynecol Pathol 2 275-285.
353. DJ Dabbs and KR Geisinger (1993) Selective application of immunohistochemistry in gynecological neoplasms. Pathol Ann 28(Pt 1), 329-353.
354. RC Bast, M Freeney, H Lazarus, et al. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68 1331-1337.
355. IA Koelma, M Nap, CJ Rodenburg, et al. (1987) The value of tumor marker CA-125 in surgical pathology. Histopathology 11 287-294.
356. Y Nanbu, S Fujii, I Konishi, et al. (1990) Immunohistochemical localization of CA-130 in fetal tissue and in normal and neoplastic tissues of the female genital tract. Asia Oceania J Obstet Gynecol 16 379-387.
357. S Tamura, K Yamaguchi, M Terada, et al. (1992) Immunohistochemical analysis of CA19-9, SLX and CA-125 in adenoidcystic carcinoma of trachea and bronchus. Nippon Kyobu Shikkan Gakkai Zasshi 3 407-411.
358. J Zhou, Y Iwasa, I Konishi, et al. (1995) Papillary serous carcinoma of the peritoneum in women: A clinicopathologic and immunohistochemical study. Cancer 76 429-436.
359. EJ Nouwen, DE Pollet, MW Eerdekens, et al. (1986) Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen and cancer antigen 125 in normal and neoplastic human lung. Cancer Res 46 866-876.
360. AC Bateman, RK al-Talib, T Newman, et al. (1997) Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA-125 and HBME-1 expression. Histopathology 30 49-56.
361. M Nap (1998) Immunohistochemistry of CA-125: unusual expression in normal tissues, distribution in the human fetus and questions around its application in diagnostic pathology. Int J Biol Markers 13 210-215.
362. TJ O'Brien, LM Raymond, GA Bannon, et al. (1991) New monoclonal antibodies identify the glycoprotein carrying the CA-125 epitope. Am J Obst Gynecol 61 1857-1864.
363. H Okamoto, Y Matsuno, M Noguchi, et al. (1992) Malignant pleural mesothelioma producing chorionic gonadotropin: report of two cases. Am J Surg Pathol 16 969-974.
364. P McAuley, SL Asa, B Chiv, et al. (1990) Parathyroid hormone-like peptide in normal and neoplastic mesothelial cells. Cancer 66 1975-1979.
365. H Tateyama, T Eimoto, T Tada, et al. (1999) Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol 111 235-240.
366. SP Hammar, D Bockus and F Remington (1987) Metastatic tumors of unknown origin: an ultrastructural analysis of 265 cases. Ultrastruct Pathol 11 209-250.
367. AO Gaber, P Rice, C Eaton, et al. (1983) Metastatic malignant disease of unknown origin. Am J Surg Pathol 145 493-497.
368. TB Crotty, JL Myers, AL Katzenstein, et al. (1994) Localized malignant mesothelioma: a clinicopathologic and flow cytometric study. Am J Surg Pathol 18 357-363.
369. M Briselli, EJ Mark and GR Dickersin (1981) Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 47 2678-2689.
370. J Doucet, I Dardick, JR Srigley, et al. (1986) Localized fibrous tumour of serosal surfaces. Virch Arch Pathol Anat 409 349-363.
371. DM England, L Hochholzer and MJ McCarthy (1989) Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13 640-658.
372. M van de Rijn, CM Lombard and RV Rouse (1994) Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum and lung. Am J Surg Pathol 18 814-820.
373. A Flint and SW Weiss (1995) CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol 26 428-431.
374. T Hasegawa, Y Matsuno, T Shimoda, et al. (1998) Frequent expression of bcl-2 protein in solitary fibrous tumors. Jpn J Clin Oncol 28 86-91.
375. G Babolini and A Blasi (1956) The pleural form of primary cancer of the lung. Dis Chest 29 314-323.
376. TR Harwood, DR Gracey and H Yokoo (1976) Pseudomesotheliomatous carcinoma of the lung. Am J Clin Pathol 65 159-167.
377. M Koss, W Travis, C Moran, et al. (1992) Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol 9 117-123.
378. C-A Hartman and H Schutze (1994) Mesothelioma-like tumors of the pleura: a review of 72 cases. Cancer Res Clin Oncol 120 331-347.
379. MN Koss, M Fleming, RM Przygodzki, et al. (1998) Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases. Ann Diagn Pathol 2 93-102.
380. JA Robb, SP Hammar and H Yokoo (1993) Pseudomesotheliomatous carcinoma of lung. Lab Invest 68 134A.
381. RL Attanoos and AR Gibbs (2003) ‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 43 444-452.
382. H Battifora (1993) Epithelioid hemangioendothelioma imitating mesothelioma. Appl Immunohistochem 1 220-221.
383. BT-Y Lin, T Colby, AM Gown, et al. (1996) Malignant vascular tumors of the serous membranes mimicking mesothelioma: A report of 14 cases. Am J Surg Pathol 20 1431-1439.
384. MH Gray, AE Rosenberg, GR Dickersin, et al. (1990) Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol 21 212-217.
385. NB Pinkard, RW Wilson, N Lawless, et al. (1996) Calcifying fibrous pseudotumor of pleura: A report of three cases of a newly described entity involving the pleura. Am J Clin Pathol 105 189-194.
386. RW Wilson, F Galateau-Salle and CA Moran (1999) Desmoid tumors of the pleura: a clinicopathologic mimic of localized fibrous tumor. Mod Pathol 12 9-14.
387. CA Moran, WD Travis, M Rosada-de-Christenson, et al. (1992) Thymomas presenting as pleural tumors: report of eight cases. Am J Surg Pathol 16 138-144.
388. CB Payne Jr, WA Morningstar and EH Chester (1966) Thymoma of the pleura masquerading as diffuse mesothelioma. Am Rev Respir Dis 94 441-446.
389. K Honma and K Shimada (1986) Metastasizing ectopic thymoma arising in the right thoracic cavity and mimicking diffuse pleural mesothelioma: An autopsy study of a case with review of the literature. Wien Klin Wschr 98 14-20.
390. D Shih, J Wang, H Tseng, et al. (1997) Primary pleural thymoma. Arch Pathol Lab Med 121 79-82.
391. E Gaertner, H Zeren, MV Fleming, et al. (1996) Biphasic synovial sarcomas arising in the pleural cavity: a clinicopathologic study of five cases. Am J Surg Pathol 20 36-45.
392. AG Nicholson, P Goldstraw and C Fischer (1998) Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: a clinicopathological and immunohistochemical review of three cases. Histopathology 33 508-513.
393. AS Colwell, J D'Cunha, SO Vargas, et al. (2002) Synovial sarcoma of the pleura: a clinical and pathologic study of three cases. J Thorac Cardiovasc Surg 124 828-832.
394. M Yano, S Toyooka, K Tsukuda, et al. (2004) SYT-SSX fusion genes in synovial sarcoma of the thorax. Lung Cancer 44 391-397.
395. NG Ordonez, SM Mahfouz and B Mackay (1990) Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol 21 733-749.
396. Y Hachitanda, C Aoyama, JK Sato, et al. (1993) Pleuropulmonary blastoma in childhood. A tumor of divergent differentiation. Am J Surg Pathol 17 382-391.
397. JR Priest, MB McDermott, S Bhatia, et al. (1997) Pleuropulmonary blastoma: a clinicopathologic study of 50 cases. Cancer 80 147-161.
398. DA Hill, S Sadeghi, MZ Schultz, et al. (1999) Pleuropulmonary blastoma in an adult: an initial case report. Cancer 85 2368-2374.
399. PA Fetsch, A Abati and YM Hijazi (1998) Utility of the antibodies CA-19-9, HBME-1 and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology. Cancer 84 101-108.
400. A Khoor, JA Whitsett, MT Stahlman, et al. (1999) Utility of surfactant protein B precursor and thyroid transcription factor-1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 30 695-700.
401. PM Curry, DN Butcher, C Fisher, et al. (2000) Value of the mesothelium associated antibodies thrombomodulin, cytokeratin 5/6, calretinin and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13 107-112.
402. J Oates and C Edwards (2000) HBME-1, MOC-31, WT-1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 36 341-342.
403. DC Chieng, H Yee, D Schaefer, et al. (2000) Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 25 194-200.
404. NG Ordonez (1999) Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma: review and update. Am J Clin Pathol 112 75-89.
405. NG Ordonez (2002) Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. Hum Pathol 33 953-967.
406. NG Ordonez (2003) The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27 1031-1051.
407. CE Commin, L Novelli, V Boddi, et al. (2001) Calretinin, thrombomodulin, CEA and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol 32 529-536.
408. PJ Zhang, EM Genega, JE Tomaszewski, et al. (2003) The role of calretinin, inhibin, melan-A, BCL-2 and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 16 591-597.
409. WB Laskin and M Miettinen (2003) Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis. Arch Pathol Lab Med 127 1161-1168.
410. C Pan, DC Chen, T Choo, et al. (2003) Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol 34 1155-1162.
411. SW Fine, SA McClain and M Li (2004) Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas. Am J Clin Pathol 122 552-559.
412. L Bergmann, U Maurer and E Weidmann (1997) Wilms tumor gene expression in acute myeloid leukemias. Leuk Lymphoma 25 435-443.
413. H Sugiyama (1998) Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia. Leuk Lymphoma 30 55-61.
414. H Hwang, L Quenneville, H Yaziji, et al. (2004) Wilms tumor gene product: sensitive and contextually specific marker of serous carcinoma of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol 12 122-126.
415. DF Carpentieri, K Nichols, PM Chou, et al. (2002) The expression of WT-1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 15 1080-1086.
416. B Davidson, R Reich, P Lazarovici, et al. (2004) Expression of the nerve growth factor receptor TrkA and p75 in malignant mesothelioma. Lung Cancer 44 159-165.
417. SP Hammar, DE Bockus, FL Remington, et al. (1996) Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas. Ultra Pathol 20 293-325.
418. FG Mayall and AR Gibbs (1992) The histology and immunohistochemistry of small cell mesothelioma. Histopathology 20 47-51.
419. FG Mayall, B Jasani and AR Gibbs (1992) Immunohistochemical positivity for neuron specific enolase and Leu 7 in malignant mesotheliomas. J Pathol 165 325-328.
420. G Falconieri, F Zanconati, R Bussani, et al. (1995) Small cell carcinoma of lung simulating mesothelioma. Pathol Res Pract 191 1147-1151.
421. DW Henderson, HD Atwood, TJ Constance, et al. (1988) Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol 12 367-384.
422. D Daya and WTE McCaughey (1990) Well-differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases. Cancer 65 292-296.
423. R Yesner and A Hurwitz (1953) Localized pleural mesothelioma of epithelial type. J Thorac Surg 26 325-329.
424. DR Thickett, L Armstrong and AB Millar (1999) Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 54 707-710.
425. A Golden and J Ash (1990) Adenomatoid tumors of genital tract. Am J Pathol 14 63-80.
426. PA Isotalo, GL Keeney, TJ Sebo, et al. (2003) Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literature. Am J Surg Pathol 27 969-977.
427. K Overstreet, C Wixum, A Shabaik, et al. (2003) Adenomatoid tumor of the pancreas: a case report with comparison of histology and aspiration cytology. Mod Pathol 16 613-617.
428. P Argani and J Rosai (1998) Hyperplastic mesothelial cells in lymph nodes. Report of six cases of a benign process that simulates metastatic involvement by mesothelioma or carcinoma. Am J Surg Pathol 29 339-346.
429. JSJ Brooks, VA LiVolsi and GG Pietra (1990) Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 93 741-748.
430. NG Ordonez, JY Ro and AG Ayal (1998) Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes. Am J Surg Pathol 22 285-292.
431. J Sussman and J Rosai (1990) Lymph node metastasis as the initial manifestation of malignant mesothelioma: Report of six cases. Am J Surg Pathol 14 819-828.
432. M Kannerstein, J Churg, WTE McCaughey, et al. (1977) Papillary tumors of the peritoneum in women: mesothelioma or papillary carcinoma. Am J Obstet Gynecol 127 306-314.
433. A Foyle, M Al-Jabi and WTE McCaughey (1981) Papillary peritoneal tumors in women. Am J Surg Pathol 5 241-249.
434. SE Mills, WA Andersen, RE Fechner, et al. (1988) Serous surface papillary carcinomas: a clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma. Am J Surg Pathol 12 827-834.
435. DJ Bollinger, MR Wick, LP Dehner, et al. (1989) Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison. Am J Surg Pathol 13 659-670.
436. U Raju, G Fine, KA Greenwald, et al. (1989) Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol 20 426-436.
437. DA Bell and RE Scully (1989) Benign and borderline serious lesions of the peritoneum in women. Pathol Ann 24(Pt 2), 1-21.
438. ML Rutledge, EG Silva, D McLemore, et al. (1989) Serous surface carcinoma of the ovary and peritoneum: A flow cytometric study. Pathol Ann 24(Pt 2), 227-235.
439. DA Bell and RE Scully (1990) Serous boderline tumors of the peritoneum. Am J Surg Pathol 14 230-239.
440. LD Truong, ML Maccato, H Awalt, et al. (1990) Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol 21 99-110.
441. CV Biscotti and WR Hart (1992) Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum): A clinicopathologic study of 17 cases. Am J Surg Pathol 16 467-475.
442. IA Shah, L Jayram, OS Gani, et al. (1998) Papillary serous carcinoma of the peritoneum in a man. Cancer 82 860-866.
443. N Khoury, R Raju, JD Crissman, et al. (1990) A comparative immunohistochemical study of peritoneal and ovarian tumors, and mesotheliomas. Hum Pathol 21 811-819.
444. DR Taylor, W Page, D Huges, et al. (1987) Metastatic renal cell carcinoma mimicking pleural mesothelioma. Thorax 42 901-902.
445. NG Ordonez, M Myhre and B Mackay (1996) Clear cell mesothelioma. Ultrastruct Pathol 20 331-336.